Clinical Trial: A Safety Study of LBH589 (Panobinostat) and RAD001 (Everolimus) to Stabilize Kidney Cancer
Sponsor and CollaboratorsRoswell Park Cancer Institute
ContactContact: Roswell Park Cancer Institute
1-877-ASK-RPCI
AskRPCI@roswellpark.org
Principal InvestigatorRoberto Pili, MD Roswell Park Cancer Institute
ClinicalTrials.gov IdentifierNCT01037257